All doorways
The full map.
Every pathway on the site, grouped three ways — by how it feels, by what your body's doing, and by the context you're in. Jump to any section below.
Tier 1 · I know what I need
Skip straight to it.
Relief finder
Pick a symptom, see the supplements, practices, recipes and treatments most worth trying.
Symptom guides
Plain-English deep dives, what each symptom is, why it shows up, and what helps.
I want to get assessed for ADHD or autism
The practical map — doctor referrals, Right-to-Choose, private routes, and how to live well while you wait.
Tier 2 · Browse the full map
Same pathways, three ways in. Pick the axis that fits how you think.
By what your body's doing
The clinical domains.
Also worth reading
Cross-cutting long-reads and evidence libraries.
Some topics cut across many pathways rather than living inside one. These are the reference reads and source libraries the pathway pages link out to.
- Read the long read
Long read
Autoimmune & menopause
The differential-diagnosis lens for symptoms that look menopausal but keep not adding up — Hashimoto's, Sjögren's, RA, PMR, LADA, PBC and more. Companion sources at /evidence/autoimmune.
- See the sources
Evidence library
Postmenopause sources
The 12-month rule, SWAN hot-flash duration, GSM and vaginal estrogen, phantom cycles, and bone & heart after the final period. Every claim linked to its named source.
- See the sources
Evidence library
Heart & metabolism sources
The AHA scientific statement, PREDIMED, the timing hypothesis, and the honest gap where diabetes and menopause overlap. Bring it to your next appointment.
- See the sources
Evidence library
PCOS / PMOS across midlife
PMOS (Polycystic Metabolic Ovarian Syndrome) is the newer name for PCOS — the metabolic side gets louder in midlife, not quieter. The 2023 Monash/ESHRE/ASRM guideline, endometrial-cancer meta-analysis, GLP-1 evidence, and the transdermal-first HRT framing.
- See the sources
Evidence library
Fibroids across midlife
The most common tumour in the female body — and one of the most under-treated in gynaecology, especially for Black women. NICE NG88, LIBERTY 1 & 2 (relugolix), Elaris UF, EMMY/REST on UAE, and the ovary-sparing evidence at hysterectomy.
Looking for the other one?
Doorways are entry points into a moment you're in. If you'd rather read and learn — long reads on hormones, treatments, and research — the Library is the other door.